Seller record · Research vendor

Core Peptides

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician appears anywhere on the site. Sales involve no prescriber. 2 more criteria also fail; see the table below.

At a glance

Core PeptidesResearch vendor

5/8criteria passed
Price
Printed on its own pages before sign-up
Sells
BPC-157, TB-500, KPV, and 6 more
FDA letters
None on file
Visit Core PeptidesSee all eight dispositions

Research vendor. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A research-chemical vendor selling peptide vials with open carts and published lot testing. It states plainly that it is not a pharmacy.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementFAILCore Peptides' website
S2Prescription gatingFAILCore Peptides' BPC-157 product page
S3Pharmacy identificationFAILCore Peptides' terms
S4Compounding disclosurePASSCore Peptides' terms
S5Analytical documentationPASSCore Peptides' BPC-157 product page
S6Business addressPASSCore Peptides' contact page
S7Price disclosurePASSCore Peptides' BPC-157 product page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician appears anywhere on the site. Sales involve no prescriber.Source: Core Peptides' website.
S2FAILProducts add to cart directly. No evaluation step exists.Source: Core Peptides' BPC-157 product page.
S3FAILThe terms state the company is not a 503A pharmacy or 503B facility.Source: Core Peptides' terms.
S4PASSSells no compounded drugs and says so; products are labeled research use only.Source: Core Peptides' terms.
S5PASSPer-lot certificates of analysis published as documents on product pages.Source: Core Peptides' BPC-157 product page.
S6PASSA stated Orlando, Florida street address with a phone number.Source: Core Peptides' contact page.
S7PASSPrices are printed on every product page, with no account or intake required.Source: Core Peptides' BPC-157 product page.
S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: BPC-157, TB-500, KPV, Semax, Epitalon, DSIP, MOTS-c, NAD+, sermorelin blends.

Visit Core Peptides

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.